PL3613436T3 - Doustna zawiesina temozolomidu - Google Patents
Doustna zawiesina temozolomiduInfo
- Publication number
- PL3613436T3 PL3613436T3 PL18306683T PL18306683T PL3613436T3 PL 3613436 T3 PL3613436 T3 PL 3613436T3 PL 18306683 T PL18306683 T PL 18306683T PL 18306683 T PL18306683 T PL 18306683T PL 3613436 T3 PL3613436 T3 PL 3613436T3
- Authority
- PL
- Poland
- Prior art keywords
- temozolomide
- oral suspension
- oral
- suspension
- Prior art date
Links
- BPEGJWRSRHCHSN-UHFFFAOYSA-N Temozolomide Chemical compound O=C1N(C)N=NC2=C(C(N)=O)N=CN21 BPEGJWRSRHCHSN-UHFFFAOYSA-N 0.000 title 1
- 229940100692 oral suspension Drugs 0.000 title 1
- 229960004964 temozolomide Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18306683.6A EP3613436B1 (en) | 2018-12-13 | 2018-12-13 | Oral suspension of temozolomide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3613436T3 true PL3613436T3 (pl) | 2021-11-29 |
Family
ID=65278117
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL18306683T PL3613436T3 (pl) | 2018-12-13 | 2018-12-13 | Doustna zawiesina temozolomidu |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US11730732B2 (pl) |
| EP (1) | EP3613436B1 (pl) |
| DK (1) | DK3613436T3 (pl) |
| ES (1) | ES2877116T3 (pl) |
| PL (1) | PL3613436T3 (pl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021009700A1 (en) * | 2019-07-16 | 2021-01-21 | Intas Pharmaceuticals Ltd. | Pharmaceutical composition of temozolomide. |
| WO2021229442A1 (en) * | 2020-05-12 | 2021-11-18 | Shorla Pharma Ltd | Stable formulations of temozolomide for oral administration |
| GB202212240D0 (en) * | 2022-08-23 | 2022-10-05 | Sigrid Therapeutics Ab | New formulations and medical uses thereof |
| GB202212239D0 (en) * | 2022-08-23 | 2022-10-05 | Sigrid Therapeutics Ab | New dietary supplements |
| CN116889564B (zh) * | 2023-06-14 | 2025-10-24 | 山东第二医科大学附属医院 | 一种新型替莫唑胺制剂及其用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1706407A2 (en) | 2003-12-30 | 2006-10-04 | Chemagis Ltd. | Novel crystalline forms of temozolomide |
| WO2008111092A1 (en) | 2007-03-09 | 2008-09-18 | Fresenius Kabi Oncology Limited | Crystalline temozolomide monohydrate and process for preparation thereof |
| US11147810B2 (en) * | 2017-03-13 | 2021-10-19 | Ftf Pharma Private Limited | Pharmaceutical composition of oral suspension of anti-neoplastic alkylating agents |
| WO2018200034A1 (en) * | 2017-04-28 | 2018-11-01 | Amplipharm Pharmaceuticals, LLC | Device and kit for dosing and dispensing non-liquid medicine |
-
2018
- 2018-12-13 EP EP18306683.6A patent/EP3613436B1/en active Active
- 2018-12-13 ES ES18306683T patent/ES2877116T3/es active Active
- 2018-12-13 PL PL18306683T patent/PL3613436T3/pl unknown
- 2018-12-13 DK DK18306683.6T patent/DK3613436T3/da active
-
2019
- 2019-12-13 US US16/713,096 patent/US11730732B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ES2877116T3 (es) | 2021-11-16 |
| EP3613436B1 (en) | 2021-06-02 |
| US11730732B2 (en) | 2023-08-22 |
| EP3613436A1 (en) | 2020-02-26 |
| US20200188390A1 (en) | 2020-06-18 |
| DK3613436T3 (da) | 2021-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201804514D0 (en) | Treatment of pyroptosis | |
| IL276592A (en) | History of Subtirum | |
| GB201806072D0 (en) | Methods of manufacture | |
| PT3577125T (pt) | Formas cristalinas de tenofovir alafenamida | |
| ZA201906464B (en) | Crystalline forms of (s)-afoxolaner | |
| ZA201701487B (en) | Powder oral suspension formulations of antibacterial agents | |
| PT3328867T (pt) | Forma cristalina de base livre de lorlatinib | |
| ZAA201800743S (en) | Parts of oral care implements | |
| DK3613436T3 (da) | Oral suspension af temozolomid | |
| PL3532457T3 (pl) | Postacie krystaliczne hydroksynorketaminy | |
| GB201804515D0 (en) | Treatment of necroptosis | |
| IL270961A (en) | Crystalline form of N-butyldeoxygalactonogirimycin | |
| ZA202105399B (en) | Use of spiropidion | |
| GB201805904D0 (en) | Methods of Manufacture | |
| GB201908109D0 (en) | Use of oral chew | |
| IL283593A (en) | Bernaflam oral preparations | |
| IL276107A (en) | Crystalline forms of psoorstam | |
| PT3781172T (pt) | Tratamento da pneumonia | |
| SG11202105136WA (en) | Application of chidamide | |
| GB201912411D0 (en) | Crystalline forms of ivosidenib | |
| IL283421A (en) | Crystalline forms of Refroxlap | |
| PT3901141T (pt) | Nova forma de isoquinolinossulfonamida | |
| GB201915908D0 (en) | Crystalline forms of entrectinib | |
| IL270937A (en) | Crystalline forms of saltalicib | |
| ZA201908255B (en) | Treatment of oral candidiasis |